Artal Group
Latest statistics and disclosures from Artal Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CAVA, LXRX, SRRK, KYMR, ARWR, and represent 65.34% of Artal Group's stock portfolio.
- Added to shares of these 10 stocks: ARWR (+$69M), CRNX (+$65M), MDGL (+$30M), XBI (+$24M), VERA (+$22M), SLDB (+$21M), VKTX (+$21M), MRUS (+$21M), KYMR (+$20M), NAMS (+$19M).
- Started 35 new stock positions in GERN, MGX, VKTX, ANRO, MRUS, APLT, AXSM, NAMS, ATXS, KYTX.
- Reduced shares in these 10 stocks: CAVA (-$385M), CYTK (-$50M), ARGX (-$44M), FOLD (-$41M), Mirati Therapeutics (-$29M), Harpoon Therapeutics (-$15M), NTRA (-$13M), RVMD (-$12M), ROIV (-$11M), SDGR (-$11M).
- Sold out of its positions in ARGX, CERE, CRIS, Cymabay Therapeutics, Fusion Pharmaceuticals, Harpoon Therapeutics, IKNA, ITOS, BZ, LLY. Mirati Therapeutics, NTRA, RELY, REPL, SDGR, SNTI, ME, XLO, ROIV.
- Artal Group was a net seller of stock by $-161M.
- Artal Group has $3.9B in assets under management (AUM), dropping by 30.48%.
- Central Index Key (CIK): 0001053906
Tip: Access up to 7 years of quarterly data
Positions held by Artal Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Portfolio Holdings for Artal Group
Artal Group holds 108 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Cava Group Ord (CAVA) | 47.3 | $1.9B | -17% | 27M | 70.05 |
|
Lexicon Pharmaceuticals Com New (LXRX) | 7.2 | $282M | 118M | 2.40 |
|
|
Scholar Rock Hldg Corp (SRRK) | 5.1 | $200M | 11M | 17.76 |
|
|
Kymera Therapeutics (KYMR) | 3.1 | $122M | +19% | 3.0M | 40.20 |
|
Arrowhead Pharmaceuticals Call Option (ARWR) | 2.6 | $104M | +196% | 3.6M | 28.60 |
|
Morphic Hldg (MORF) | 2.0 | $78M | +3% | 2.2M | 35.20 |
|
Apellis Pharmaceuticals (APLS) | 2.0 | $77M | -7% | 1.3M | 58.78 |
|
Springworks Therapeutics (SWTX) | 1.8 | $70M | -12% | 1.4M | 49.22 |
|
Crinetics Pharmaceuticals In (CRNX) | 1.7 | $65M | NEW | 1.4M | 46.81 |
|
Beigene Sponsored Adr (BGNE) | 1.6 | $63M | 405k | 156.39 |
|
|
Silence Therapeutics Ads (SLN) | 1.5 | $60M | -7% | 2.8M | 21.60 |
|
Dyne Therapeutics (DYN) | 1.1 | $43M | +24% | 1.5M | 28.39 |
|
Revolution Medicines (RVMD) | 1.1 | $43M | -22% | 1.3M | 32.23 |
|
Kura Oncology (KURA) | 1.0 | $41M | +8% | 1.9M | 21.33 |
|
Neumora Therapeutics (NMRA) | 1.0 | $40M | +14% | 2.9M | 13.75 |
|
Korro Bio (KRRO) | 1.0 | $38M | 419k | 90.00 |
|
|
Cytokinetics Com New (CYTK) | 0.9 | $36M | -58% | 507k | 70.11 |
|
Solid Biosciences Com New (SLDB) | 0.8 | $33M | +174% | 2.5M | 13.32 |
|
Igm Biosciences (IGMS) | 0.8 | $30M | 3.1M | 9.65 |
|
|
Madrigal Pharmaceuticals (MDGL) | 0.8 | $30M | NEW | 111k | 267.04 |
|
Glycomimetics (GLYC) | 0.7 | $26M | 8.6M | 3.00 |
|
|
WAVE Life Sciences SHS (WVE) | 0.6 | $25M | +34% | 4.1M | 6.17 |
|
Prothena Corp SHS (PRTA) | 0.6 | $25M | +99% | 1.0M | 24.77 |
|
Spdr Ser Tr S&p Biotech Call Option (XBI) | 0.6 | $24M | NEW | 250k | 94.89 |
|
Vera Therapeutics Cl A (VERA) | 0.6 | $22M | NEW | 506k | 43.12 |
|
Viking Therapeutics (VKTX) | 0.5 | $21M | NEW | 254k | 82.00 |
|
Merus N V (MRUS) | 0.5 | $21M | NEW | 455k | 45.03 |
|
NewAmsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $19M | NEW | 800k | 23.65 |
|
Tango Therapeutics (TNGX) | 0.4 | $17M | NEW | 2.2M | 7.94 |
|
Acelyrin (SLRN) | 0.4 | $16M | -20% | 2.4M | 6.75 |
|
Alpine Immune Sciences | 0.4 | $16M | +699% | 406k | 39.64 |
|
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $16M | +39% | 1.4M | 11.30 |
|
Gossamer Bio Call Option (GOSS) | 0.4 | $16M | +10% | 14M | 1.18 |
|
Edgewise Therapeutics (EWTX) | 0.4 | $15M | NEW | 812k | 18.24 |
|
Syros Pharmaceuticals Com New (SYRS) | 0.3 | $13M | 2.5M | 5.35 |
|
|
Sea Sponsored Ads (SE) | 0.3 | $13M | -36% | 238k | 53.71 |
|
Lexeo Therapeutics (LXEO) | 0.3 | $13M | +32% | 802k | 15.68 |
|
Astria Therapeutics (ATXS) | 0.3 | $12M | NEW | 884k | 14.07 |
|
Amicus Therapeutics (FOLD) | 0.3 | $12M | -77% | 1.0M | 11.78 |
|
Generation Bio (GBIO) | 0.3 | $12M | 2.8M | 4.07 |
|
|
Xenon Pharmaceuticals (XENE) | 0.3 | $11M | NEW | 253k | 43.05 |
|
Celldex Therapeutics Com New (CLDX) | 0.3 | $11M | NEW | 253k | 41.97 |
|
Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $11M | 3.7M | 2.87 |
|
|
Denali Therapeutics (DNLI) | 0.3 | $10M | -37% | 503k | 20.52 |
|
Apogee Therapeutics (APGE) | 0.3 | $10M | NEW | 153k | 66.45 |
|
Erasca (ERAS) | 0.2 | $9.7M | 4.7M | 2.06 |
|
|
Agenus Com New | 0.2 | $9.1M | 16M | 0.58 |
|
|
Seer Com Cl A (SEER) | 0.2 | $9.0M | 4.8M | 1.90 |
|
|
Ultragenyx Pharmaceutical (RARE) | 0.2 | $8.3M | NEW | 178k | 46.69 |
|
Elevation Oncology (ELEV) | 0.2 | $7.8M | NEW | 1.5M | 5.13 |
|
Ovid Therapeutics (OVID) | 0.2 | $7.6M | 2.5M | 3.05 |
|
|
Tourmaline Bio (TRML) | 0.2 | $7.2M | +243% | 315k | 22.90 |
|
Applied Therapeutics (APLT) | 0.2 | $6.9M | NEW | 1.0M | 6.80 |
|
PDD Holdings Sponsored Ads (PDD) | 0.2 | $6.6M | +73% | 57k | 116.25 |
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $6.5M | +75% | 152k | 42.86 |
|
Vigil Neuroscience (VIGL) | 0.2 | $6.2M | 1.8M | 3.41 |
|
|
Axsome Therapeutics (AXSM) | 0.2 | $6.1M | NEW | 77k | 79.80 |
|
Selecta Biosciences | 0.2 | $5.9M | 9.1M | 0.65 |
|
|
Alto Neuroscience (ANRO) | 0.1 | $5.4M | NEW | 350k | 15.35 |
|
Black Diamond Therapeutics (BDTX) | 0.1 | $5.3M | -48% | 1.0M | 5.07 |
|
Regenxbio Inc equity us cm (RGNX) | 0.1 | $5.3M | NEW | 250k | 21.07 |
|
Allovir (ALVR) | 0.1 | $5.0M | 6.6M | 0.75 |
|
|
Kyverna Therapeutics (KYTX) | 0.1 | $5.0M | NEW | 200k | 24.84 |
|
Foghorn Therapeutics (FHTX) | 0.1 | $4.8M | 721k | 6.71 |
|
|
Omega Therapeutics (OMGA) | 0.1 | $4.8M | 1.3M | 3.65 |
|
|
Paypal Holdings Call Option (PYPL) | 0.1 | $4.6M | +7% | 68k | 66.99 |
|
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.1 | $4.4M | -52% | 32k | 136.05 |
|
Geron Corporation (GERN) | 0.1 | $4.2M | NEW | 1.3M | 3.30 |
|
Stoke Therapeutics (STOK) | 0.1 | $4.1M | NEW | 300k | 13.50 |
|
Hookipa Pharma Inc equity (HOOK) | 0.1 | $4.0M | 5.7M | 0.71 |
|
|
Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $3.9M | -21% | 725k | 5.42 |
|
Ke Holdings Sponsored Ads (BEKE) | 0.1 | $3.8M | +10% | 275k | 13.73 |
|
Repare Therapeutics Ord (RPTX) | 0.1 | $3.3M | 700k | 4.71 |
|
|
Metagenomi (MGX) | 0.1 | $3.2M | NEW | 300k | 10.55 |
|
Pepgen (PEPG) | 0.1 | $2.9M | NEW | 200k | 14.70 |
|
Adagene Ads (ADAG) | 0.1 | $2.9M | +2% | 1.0M | 2.80 |
|
Gritstone Oncology Ord (GRTS) | 0.1 | $2.6M | NEW | 1.0M | 2.57 |
|
Fate Therapeutics (FATE) | 0.1 | $2.6M | NEW | 360k | 7.34 |
|
Vor Biopharma (VOR) | 0.1 | $2.4M | -57% | 1.0M | 2.37 |
|
Amazon (AMZN) | 0.1 | $2.2M | 12k | 180.38 |
|
|
Janux Therapeutics (JANX) | 0.0 | $1.9M | NEW | 50k | 37.65 |
|
NVIDIA Corporation (NVDA) | 0.0 | $1.7M | NEW | 1.9k | 903.56 |
|
Apple (AAPL) | 0.0 | $1.7M | NEW | 10k | 171.48 |
|
Dynatrace Com New (DT) | 0.0 | $1.7M | NEW | 36k | 46.44 |
|
Adobe Systems Incorporated (ADBE) | 0.0 | $1.6M | NEW | 3.1k | 504.60 |
|
New Oriental Ed & Technology Sponsored Adr (EDU) | 0.0 | $1.3M | NEW | 15k | 86.82 |
|
Datadog Cl A Com (DDOG) | 0.0 | $1.2M | +28% | 9.6k | 123.60 |
|
Kronos Bio (KRON) | 0.0 | $1.1M | 843k | 1.30 |
|
|
Alphabet Cap Stk Cl A (GOOGL) | 0.0 | $1.1M | -10% | 7.0k | 150.93 |
|
Microsoft Corporation (MSFT) | 0.0 | $1.1M | 2.5k | 420.72 |
|
|
Snowflake Cl A (SNOW) | 0.0 | $1.1M | NEW | 6.5k | 161.60 |
|
Intapp (INTA) | 0.0 | $1.0M | +68% | 30k | 34.30 |
|
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $963k | 111k | 8.71 |
|
|
Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $944k | -66% | 755k | 1.25 |
|
Palo Alto Networks (PANW) | 0.0 | $852k | NEW | 3.0k | 284.13 |
|
Advanced Micro Devices (AMD) | 0.0 | $812k | +80% | 4.5k | 180.49 |
|
Procore Technologies (PCOR) | 0.0 | $781k | 9.5k | 82.17 |
|
|
Pegasystems (PEGA) | 0.0 | $743k | 12k | 64.64 |
|
|
MongoDB Cl A (MDB) | 0.0 | $717k | +100% | 2.0k | 358.64 |
|
Visa Com Cl A (V) | 0.0 | $698k | 2.5k | 279.08 |
|
|
Confluent Class A Com (CFLT) | 0.0 | $580k | 19k | 30.52 |
|
|
Caribou Biosciences (CRBU) | 0.0 | $542k | 105k | 5.14 |
|
|
Cyclerion Therapeutics (CYCN) | 0.0 | $445k | 139k | 3.20 |
|
|
Clearwater Analytics Hldgs I Cl A (CWAN) | 0.0 | $442k | +25% | 25k | 17.69 |
|
Dlocal Class A Com (DLO) | 0.0 | $441k | +50% | 30k | 14.70 |
|
Hippo Hldgs Com New (HIPO) | 0.0 | $439k | 24k | 18.27 |
|
|
Tesla Motors (TSLA) | 0.0 | $352k | NEW | 2.0k | 175.79 |
|
Mink Therapeutics (INKT) | 0.0 | $1.7k | 1.9k | 0.91 |
|
Past Filings by Artal Group
SEC 13F filings are viewable for Artal Group going back to 2012
- Artal Group 2024 Q1 restated filed May 17, 2024
- Artal Group 2024 Q1 filed May 13, 2024
- Artal Group 2023 Q4 filed Feb. 9, 2024
- Artal Group 2023 Q3 filed Nov. 13, 2023
- Artal Group 2023 Q2 filed Aug. 11, 2023
- Artal Group 2023 Q1 filed May 12, 2023
- Artal Group 2022 Q4 filed Feb. 13, 2023
- Artal Group 2022 Q3 filed Nov. 14, 2022
- Artal Group 2022 Q2 filed Aug. 11, 2022
- Artal Group 2022 Q1 filed May 12, 2022
- Artal Group 2021 Q4 filed Feb. 11, 2022
- Artal Group 2021 Q3 filed Nov. 12, 2021
- Artal Group 2021 Q2 filed Aug. 13, 2021
- Artal Group 2021 Q1 filed May 14, 2021
- Artal Group 2020 Q4 filed Feb. 11, 2021
- Artal Group 2020 Q3 filed Nov. 13, 2020